JAK-inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case Report

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Laryngoscope Pub Date : 2024-09-19 DOI:10.1002/lary.31778
Meryem Demir MD, Vasileios Kouranos PhD, Kostadin Stoenchev MD, Stephen R Durham MD, FRCP, Guy W Scadding PhD, FRCP, Nilesh Morar DPhil (Oxon), FRCP, Chadwan Al Yaghchi PhD, FRCS, Guri S Sandhu MD, FRCS (ORL-HNS), Hesham Saleh FRCS (ORL-HNS), IBFPRS
{"title":"JAK-inhibitor Tofacitinib in Severe Laryngeal Sarcoidosis: A Case Report","authors":"Meryem Demir MD,&nbsp;Vasileios Kouranos PhD,&nbsp;Kostadin Stoenchev MD,&nbsp;Stephen R Durham MD, FRCP,&nbsp;Guy W Scadding PhD, FRCP,&nbsp;Nilesh Morar DPhil (Oxon), FRCP,&nbsp;Chadwan Al Yaghchi PhD, FRCS,&nbsp;Guri S Sandhu MD, FRCS (ORL-HNS),&nbsp;Hesham Saleh FRCS (ORL-HNS), IBFPRS","doi":"10.1002/lary.31778","DOIUrl":null,"url":null,"abstract":"<p>Sarcoidosis is an inflammatory, non-caseating granulomatous multisystem disease associated with JAK-STAT (Janus kinases-signal transducer and activator of transcription proteins) pathway activation. We present a patient with severe multi-systemic sarcoidosis who showed marked improvement with tofacitinib with regards to pulmonary, cutaneous, nasal and laryngeal disease. Tofacitinib prevented critical laryngeal stenosis from progressing to tracheostomy, induced regression of cutaneous lesions and improved pulmonary function in this steroid-resistant and immunosuppressive intolerant case. This case report supports further the role of JAK-inhibitors in the treatment of systemic sarcoidosis. <i>Laryngoscope</i>, 135:829–832, 2025</p>","PeriodicalId":49921,"journal":{"name":"Laryngoscope","volume":"135 2","pages":"829-832"},"PeriodicalIF":2.0000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Laryngoscope","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/lary.31778","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Sarcoidosis is an inflammatory, non-caseating granulomatous multisystem disease associated with JAK-STAT (Janus kinases-signal transducer and activator of transcription proteins) pathway activation. We present a patient with severe multi-systemic sarcoidosis who showed marked improvement with tofacitinib with regards to pulmonary, cutaneous, nasal and laryngeal disease. Tofacitinib prevented critical laryngeal stenosis from progressing to tracheostomy, induced regression of cutaneous lesions and improved pulmonary function in this steroid-resistant and immunosuppressive intolerant case. This case report supports further the role of JAK-inhibitors in the treatment of systemic sarcoidosis. Laryngoscope, 135:829–832, 2025

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
JAK 抑制剂托法替尼治疗重度喉肉瘤病:病例报告。
肉样瘤病是一种炎症性、非酪氨酸肉芽肿性多系统疾病,与JAK-STAT(Janus激酶-信号转导和激活转录蛋白)通路激活有关。我们介绍了一名患有严重多系统肉样瘤病的患者,该患者使用托法替尼后,肺部、皮肤、鼻腔和喉部疾病均有明显改善。托法替尼避免了严重的喉部狭窄发展到气管切开,促使皮肤病变消退,并改善了这位类固醇耐药和免疫抑制剂不耐受病例的肺功能。本病例报告进一步证实了 JAK 抑制剂在治疗系统性肉样瘤病中的作用。喉镜》,2024 年。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Laryngoscope
Laryngoscope 医学-耳鼻喉科学
CiteScore
6.50
自引率
7.70%
发文量
500
审稿时长
2-4 weeks
期刊介绍: The Laryngoscope has been the leading source of information on advances in the diagnosis and treatment of head and neck disorders since 1890. The Laryngoscope is the first choice among otolaryngologists for publication of their important findings and techniques. Each monthly issue of The Laryngoscope features peer-reviewed medical, clinical, and research contributions in general otolaryngology, allergy/rhinology, otology/neurotology, laryngology/bronchoesophagology, head and neck surgery, sleep medicine, pediatric otolaryngology, facial plastics and reconstructive surgery, oncology, and communicative disorders. Contributions include papers and posters presented at the Annual and Section Meetings of the Triological Society, as well as independent papers, "How I Do It", "Triological Best Practice" articles, and contemporary reviews. Theses authored by the Triological Society’s new Fellows as well as papers presented at meetings of the American Laryngological Association are published in The Laryngoscope. • Broncho-esophagology • Communicative disorders • Head and neck surgery • Plastic and reconstructive facial surgery • Oncology • Speech and hearing defects
期刊最新文献
What Is the Role of Sentinel Lymph Node Biopsy in Recurrent Head and Neck Melanoma? Should All Patients With Recurrent Respiratory Papillomatosis Be Vaccinated for HPV? Comparative Outcomes of Transoral Versus Transcervical Approach for Extrapharyngeal Foreign Body Removal. Prevalence of Esophageal Dysmotility and Reflux in Muscle Tension Dysphonia Patients. Diagnostic and Prognostic Value of Systemic Inflammatory Markers and Serum Vitamin D in CRS.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1